Back to today’s briefing

Story perspectives

Nuclear Power Revival: Thorium-229 Targets Cancer Treatment

7/19/2025

22 5

Summary

Story summary

Nuclear power is making a comeback, driven by the urgent need for cleaner energy and surging electricity demand. In Tennessee, Oak Ridge National Laboratory is pioneering targeted alpha therapy for cancer, harnessing Thorium-229 from nuclear waste. This innovative collaboration not only boosts production but also ensures safe disposal of fissile materials, with a potential drug launch by late 2027.

1 of 1

Story summary

Nuclear power is making a comeback, driven by the urgent need for cleaner energy and surging electricity demand. In Tennessee, Oak Ridge National Laboratory is pioneering targeted alpha therapy for cancer, harnessing Thorium-229 from nuclear waste. This innovative collaboration not only boosts production but also ensures safe disposal of fissile materials, with a potential drug launch by late 2027.